The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis

İLGEN, Ufuk; DÜZGÜN, NURŞEN; YAYLA, ÇAĞRI; GAYRETLİ YAYLA, Kadriye; YAYLA, Müçteba Enes; Akboga, Mehmet Kadri

The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis

Çağrı YAYLA, (Sağlık Bakanlığı, Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Müçteba Enes YAYLA, (Ankara Üniversitesi, Tıp Fakültesi, Ankara)

Kadriye GAYRETLİ YAYLA, (Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Ufuk İLGEN, (Ankara Üniversitesi, Tıp Fakültesi, Ankara)

Mehmet Kadri AKBOĞA, (Sağlık Bakanlığı, Türkiye Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Nurşen DÜZGÜN (Ankara Üniversitesi, Tıp Fakültesi, Ankara)

Archives of Rheumatology

0 0

Yıl: 2016 Cilt: 31 Sayı: 2 Sayfa Aralığı: 139 - 144 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis

Öz:

Objectives: This study aims to investigate ventricular repolarization using T-peak to T-end (Tp-e) intervals and Tp-e/QT ratios in patients with systemic sclerosis (SSc).Patients and methods: Totally 65 patients (8 males, 57 females; mean age 49.8 years; range 20 to 77 years) with SSc and 63 control subjects (8 males, 55 females; mean age 49.3 years; range 20 to 77 years) were enrolled. Tp-e intervals, Tp-e/QT, and Tp-e/corrected QT (QTc) ratios were measured from the 12-lead electrocardiogram.Results: Tp-e intervals, QT intervals, QTc intervals, Tp-e/QT, and Tp-e/QTc ratios were significantly higher in patients with SSc than control subjects (all p<0.01). There was no difference between patients with diffuse and limited cutaneous SSc in terms of electrocardiogram and echocardiographic findings. Correlation analysis revealed no correlation between Tp-e intervals, Tp-e/QT, and Tp-e/QTc ratios with disease duration and anti-Sjögren's syndrome antigen A antibody levels in patients with SSc (all p>0.05).Conclusion: Our study showed that Tp-e intervals, Tp-e/QT, and Tp-e/QTc ratios were increased in patients with SSc than control subjects. The increased frequency of ventricular arrhythmias can be clarified by increased indexes of ventricular repolarization parameters in patients with SSc

Anahtar Kelime:

Konular: Romatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Seferovic PM, Ristic AD, Maksimovic R, Simeunovic DS, Ristic GG, Radovanovic G, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006;45:39-42.
Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J. 2007;28:1797- 804.
Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford) 2009;48:45-8.
Follansbee WP, Miller TR, Curtiss EI, Orie JE, Bernstein RL, Kiernan JM, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-62.
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA Jr, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988;84:1007-15.
Sgreccia A, Morelli S, Ferrante L, Perrone C, De Marzio P, De Vincentiis G, et al. QT interval and QT dispersion in systemic sclerosis (scleroderma). J Intern Med 1998;243:127-32.
Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 2008;41:575-80.
Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007;4:1114-6.
Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006;47:1828-34.
Smetana P, Schmidt A, Zabel M, Hnatkova K, Franz M, Huber K, et al. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. J Electrocardiol 2011;44:301-8.
Erikssen G, Liestİl K, Gullestad L, Haugaa KH, Bendz B, Amlie JP. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol 2012;17:85-94.
Zhao X, Xie Z, Chu Y, Yang L, Xu W, Yang X, et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol 2012;35:559-64.
Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008;41:567-74.
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta- analysis. Clin Rheumatol 2014;33:1099-104.
Rodríguez-Reyna TS, Morelos-Guzman M, Hernández-Reyes P, Montero-Duarte K, Martínez-Reyes C, Reyes-Utrera C, et al. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford) 2015;54:647-54.
Seung-Geun L, Young-Eun P, Su-Yeon C, Eun-Kyung P, Geun-Tae K, Ki-Seok C, et al. Systemic sclerosis is not associated with increased coronary artery calcium deposition. Arch Rheumatol 2013;28:242-50.
D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
James TN. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974;50:844-56.
Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 2012;60:1854-63.
Nerheim P, Krishnan SC, Olshansky B, Shivkumar K. Apoptosis in the genesis of cardiac rhythm disorders. Cardiol Clin 2001;19:155-63.
Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
Lubitz SA, Goldbarg SH, Mehta D. Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis 2008;51:58-73.
Nordin A, Björnådal L, Larsson A, Svenungsson E, Jensen-Urstad K. Electrocardiography in 110 patients with systemic sclerosis: a cross-sectional comparison with population-based controls. Scand J Rheumatol 2014;43:221-5.
Gialafos E, Konstantopoulou P, Voulgari C, Giavri I, Panopoulos S, Vaiopoulos G, et al. Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosis. Clin Exp Rheumatol 2012;30:327-31.
Kors JA, van Herpen G, van Bemmel JH. QT dispersion as an attribute of T-loop morphology. Circulation 1999;99:1458-63.
Yayla Ç, Bilgin M, Akboğa MK, Gayretli Yayla K, Canpolat U, Dinç Asarcikli L, et al. Evaluation of Tp-E Interval and Tp-E/QT Ratio in Patients with Aortic Stenosis. Ann Noninvasive Electrocardiol 2015 Aug 5.
Acar G, Yorgun H, Inci MF, Akkoyun M, Bakan B, Nacar AB, et al. Evaluation of Tp-e interval and Tp-e/ QT ratio in patients with ankylosing spondylitis. Mod Rheumatol 2014;24:327-30.
Acar GR, Akkoyun M, Nacar AB, Dirnak I, Yıldırım Çetin G, Nur Yıldırım M, et al. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars 2014;42:29-34.

APA	YAYLA Ç, YAYLA M, GAYRETLİ YAYLA K, İLGEN U, Akboga M, DÜZGÜN N (2016). The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. , 139 - 144.
Chicago	YAYLA ÇAĞRI,YAYLA Müçteba Enes,GAYRETLİ YAYLA Kadriye,İLGEN Ufuk,Akboga Mehmet Kadri,DÜZGÜN NURŞEN The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. (2016): 139 - 144.
MLA	YAYLA ÇAĞRI,YAYLA Müçteba Enes,GAYRETLİ YAYLA Kadriye,İLGEN Ufuk,Akboga Mehmet Kadri,DÜZGÜN NURŞEN The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. , 2016, ss.139 - 144.
AMA	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. . 2016; 139 - 144.
Vancouver	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. . 2016; 139 - 144.
IEEE	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N "The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis." , ss.139 - 144, 2016.
ISNAD	YAYLA, ÇAĞRI vd. "The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis". (2016), 139-144.

APA	YAYLA Ç, YAYLA M, GAYRETLİ YAYLA K, İLGEN U, Akboga M, DÜZGÜN N (2016). The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. Archives of Rheumatology, 31(2), 139 - 144.
Chicago	YAYLA ÇAĞRI,YAYLA Müçteba Enes,GAYRETLİ YAYLA Kadriye,İLGEN Ufuk,Akboga Mehmet Kadri,DÜZGÜN NURŞEN The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. Archives of Rheumatology 31, no.2 (2016): 139 - 144.
MLA	YAYLA ÇAĞRI,YAYLA Müçteba Enes,GAYRETLİ YAYLA Kadriye,İLGEN Ufuk,Akboga Mehmet Kadri,DÜZGÜN NURŞEN The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. Archives of Rheumatology, vol.31, no.2, 2016, ss.139 - 144.
AMA	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. Archives of Rheumatology. 2016; 31(2): 139 - 144.
Vancouver	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis. Archives of Rheumatology. 2016; 31(2): 139 - 144.
IEEE	YAYLA Ç,YAYLA M,GAYRETLİ YAYLA K,İLGEN U,Akboga M,DÜZGÜN N "The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis." Archives of Rheumatology, 31, ss.139 - 144, 2016.
ISNAD	YAYLA, ÇAĞRI vd. "The Assessment of Tp-e Interval and Tp-e/QT Ratio in Patients With Systemic Sclerosis". Archives of Rheumatology 31/2 (2016), 139-144.